Morikamm Capsule (Meloxicam)

Adult dose

1. Acute exacerbations of osteoarthritis (degenerative arthritis): ○ Adults: Administer 7.5 mg of meloxicam orally once daily. If symptoms do not improve, the dose may be increased to up to 15 mg daily as needed. 2. Rheumatoid arthritis, ankylosing spondylitis: ○ Adults: Administer 15 mg of meloxicam orally once daily. The dose may be reduced to 7.5 mg daily according to the response to treatment. Do not administer more than 15 mg of this medicine per day. The daily dose should be taken all at once with water or another beverage during a meal. ○ In older adults or patients at increased risk of adverse reactions (e.g., those with a history of gastrointestinal disease or cardiovascular risk factors), treatment should generally be initiated at a dose of 7.5 mg daily. ○ Patients with severe renal impairment receiving hemodialysis should not be administered more than 7.5 mg daily.

This drug may pose a risk of gastrointestinal bleeding for individuals who regularly consume more than three drinks of alcohol daily, so it is essential to consult with a doctor or pharmacist. Additionally, this drug may increase the risk of cardiovascular disease, so individuals with a history of heart disease or stroke, or those with risk factors, must be particularly cautious. If cardiovascular symptoms occur, the medication should be discontinued immediately, and medical attention should be sought. This drug can cause serious gastrointestinal adverse reactions such as gastrointestinal bleeding, ulcers, or perforation, so individuals with a history of gastrointestinal diseases or the elderly should use it cautiously. Serious allergic reactions may occur, so if skin rashes or mucosal damage develop, the medication should be stopped immediately. It may affect kidney function, so those with kidney disease or taking diuretics or blood pressure medication should have their kidney function regularly checked. Pregnant women or those planning to become pregnant should not take this drug, and it is also advisable not to use it during breastfeeding. The risk of gastrointestinal bleeding may increase when used in combination with other nonsteroidal anti-inflammatory drugs, so it is preferable not to take them simultaneously. Consult healthcare professionals when taken with anticoagulants, blood pressure medications, diuretics, etc., as there may be risks of bleeding or diminished drug efficacy. For long-term use, regular blood tests, liver function, and kidney function tests should be conducted to detect and respond to adverse reactions early. If dizziness, drowsiness, or visual disturbances occur during medication, it is advisable to avoid driving or operating machinery. In case of overdose, symptoms such as nausea, vomiting, gastrointestinal bleeding, and kidney and liver dysfunction may occur, requiring immediate medical attention. Keep out of reach of children and store in the original container to maintain quality.

Gastrointestinal bleeding, cardiovascular thrombotic reactions, myocardial infarction, stroke, upper gastrointestinal or intestinal bleeding, ulcers, perforation, exfoliative dermatitis, mucous membrane syndrome, toxic epidermal necrolysis, anaphylactic reactions, interstitial nephritis, glomerulonephritis, renal medullary necrosis, nephrotic syndrome, elevated serum transaminases, elevated liver function tests, increased plasma creatinine, increased blood urea nitrogen, aplastic anemia, bone marrow suppression, changes in blood cell counts, leukopenia, thrombocytopenia, anemia, decreased plasma iron, decreased hemoglobin, decreased hematocrit, increased neutrophils, increased eosinophils, increased basophils, increased monocytes, agranulocytosis, anaphylaxis, discomfort, confusion, loss of direction, mood changes, mood disorders, insomnia, nightmares, anxiety, increased appetite, depression, irritability, dizziness, drowsiness, headache, cephalalgia, fatigue, lethargy, taste dysfunction, mental confusion, convulsions, sensory disturbances, tremors, blurred vision, conjunctivitis, foreign body sensation in the eye, scleral hemorrhage, tinnitus, palpitations, elevated blood pressure, flushing, arrhythmia, tachycardia, hypotension, hypertension, myocardial infarction, angina, heart failure, vasculitis, cough, upper respiratory infection, asthma, bronchospasm, dyspnea, dyspepsia, nausea, vomiting, abdominal pain, constipation, flatulence, diarrhea, decreased appetite, peptic ulcer, occult gastrointestinal bleeding, macroscopic gastrointestinal bleeding, stomatitis, gastritis, esophagitis, belching, dry mouth, thirst, angular cheilitis, occult blood in stool, gastrointestinal perforation, colitis, pancreatitis, melena, perforated peptic ulcer, hepatitis, jaundice, liver failure, alopecia, increased sweating, skin rash, urticaria, angioedema, vesicular dermatitis, erythema multiforme, photosensitivity reactions, contact dermatitis, fixed drug eruption, urinary retention, elevated plasma creatinine, elevated urea levels, proteinuria, glucosuria, increased urine sediment, hematuria, sodium and water retention, hyperkalemia, acute renal failure, decreased urine output, pollakiuria, urinary tract infection, interstitial nephritis, edema, lower limb edema, fatigue, fever, facial edema, syncope, weight loss, weight gain, armpit and breast pain, arthralgia, low back pain, armpit and chest pain, rigidity, lower limb weakness, decreased female reproductive capacity, dehydration, drowsiness, nausea, vomiting, epigastric pain, hypertension, acute renal failure, liver failure, respiratory depression, coma, convulsions, cardiovascular collapse, cardiac arrest

This medication is sensitive to light, so it should be stored in a container that blocks light. Additionally, it is important to maintain a room temperature between 1 and 30 degrees Celsius while storing the medication. This ensures that the drug's effectiveness is well maintained and can be used safely.

Appearance

A hard capsule containing pale yellow powder, with a light green upper and lower part.

Package unit

30 capsules/bottle, 300 capsules/bottle